PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Boyer, David
TI  - Intraocular Use of Anti-VEGF Antibody Fragment Improves Vision and Retinal Anatomy in DR
DP  - 2011 Sep 01
TA  - MD Conference Express
PG  - 15--15
VI  - 11
IP  - 8
4099  - http://mdc.sagepub.com/content/11/8/15.short
4100  - http://mdc.sagepub.com/content/11/8/15.full
AB  - Ranibizumab, an anti-VEGF antibody fragment that is designed for intraocular use in diabetic retinopathy (DR), led to rapid and sustained improvement in both vision and retinal anatomy, reduced progression of DR, and improved patient-reported function in the RISE and RIDE clinical trials.